# Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis

> **NCT01287715** · PHASE4 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** etanercept
- **DRUG:** etanercept

## Key facts

- **NCT ID:** NCT01287715
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-09
- **Final completion:** 2013-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287715, "Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01287715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*